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Objectives: This study evaluated the microleakage at the implant/abutment interface of external hexagon (eH) implants and abutments with different amounts of bacteria and 
tightening torques. Material and Methods: A bacterial suspension was prepared to inoculate 
the implants. The first phase of this study used nine EH implants and abutments that were 
divided into three groups with different amounts of bacterial suspension (n=3): V0.5: 0.5 
µL; V1.0: 1.0 µL e V1.5: 1.5 µL, and tightened to the manufacturer’s recommended torque. 
The second phase of this experiment used 27 assemblies that were similar to those used 
in the first phase. These samples were inoculated with 0.5 µL of bacterial suspension and 
divided into three groups (n=9). T10: 10 Ncm; T20: 20 Ncm and T32: 32 Ncm. The samples 
were evaluated according to the turbidity of the broth every 24 hours for 14 days, and the 
bacteria viability was tested after that period. The statistical evaluation was conducted by 
Kruskal-Wallis testing (p<.05). Results: During the first phase, groups V1.0 and V1.5 was 
presented with bacterial contamination in all samples after 24 h. During the second phase, 
two samples from group T10 and one from T20 presented positive results for bacterial 
contamination. Different amounts of bacterial solution led to overflow and contamination 
during the first 24 h of the experiment. The tightening torques did not statistically affect the 
microleakage in the assemblies. However, the group that was tightened to 32 Ncm torque 
did not show any bacterial contamination. Conclusion: After 14 days of experimentation, 
the bacteria were proven to remain viable inside the implant internal cavity. 
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INTRODUCTION
Success in implant therapy demands a balance 
between biological and mechanical factors11. 
Failures in these procedures have been associated 
with a lack of stability or a misfit at the implant/
abutment (I/A) interface1,11,28. external hexagon 
(eH) implants ad modum Branemark present 
an acceptable amount of bone loss around the 
I/A interface. This bone loss is considered to be 
normal at approximately 1.0 mm for the first 
year of function and 0.2 mm thereafter1. The I/A 
interface is correlated with the presence of bacterial 
infiltration and inflammatory cells that can lead to 
bone loss around this area5,6,15,17,27.
The amount of bacterial infiltration between 
the implants and abutments depends on factors 
such as the fit accuracy between the pieces and 
the tightening torque and micro-movements 
between the connected components during 
mastication7,19,24,28,30.  Preventing bacterial 
infiltration at the I/A interface was a challenge 
that was pursued during the development of two-
stage implants. The goal was to minimize the 
J Appl Oral Sci. 582
inflammatory reaction and therefore maintain the 
bone around the implant top9,25. Implant companies 
attempt to reduce this bacterial infiltration by 
increasing the accuracy and stability of the jointed 
parts through the fabrication of mechanical pieces 
with a high degree of precision9,25,26.
The I/A interface in eH implants is reported as 
being more favorable to the infiltration of fluids than 
other joints4,10,14,16,18,23,26,29. The microgap in this 
implant design varies from 1 to 49 µm, depending 
on the type of abutment that is selected7,14. It 
represents a risk for plaque accumulation that 
favors bacterial aggregation3,14,19-22,24,26,28,30. In vitro 
studies on bacterial infiltration have used different 
species of bacteria with sizes that vary from 1 to 10 
µm3,4,9,10,12,14,16,19-21,23,24,26,29,30. Toxins and stains4,8,13 
from these bacteria14 have also been used and 
are even smaller. Escherichia coli is a facultative 
anaerobic bacteria that ranges from 1.1 to 1.5 µm 
in diameter. It has great motility and has been 
widely used in similar implant-related studies such 
as this one16,30.
Several methodologies have been used to 
evaluate the magnitude of this microgap at the 
I/A interface as well as its real influence in the 
bacterial infiltration process9,14,16,26,29. Bacterial 
infiltration has been evaluated in a two-way path, 
not only from inside the screw role to the outside 
(I/e)3,4,8,12-14,16,19,30, but also inward from the outer 
part of the implant (e/I)4,9,10,12,20,23,26. The results 
have been evaluated through qualitative methods 
of turbidity of nutrient broths4,12,14,16,19,23,24,30 and 
quantitative methods of analyzing bacterial 
DNA3,10,21. Nonetheless, all methods have several 
critical points that can either lead to false positive 
or false negative results. Some of these points 
include holding the implant with forceps; free-hand 
inoculation of the bacterial suspension inside the 
implant; sealing the entire implant by favoring 
fluids that flow inside the interface; using a single 
torquemeter for all samples; failing to determine 
the area inside the implant so that the right 
amount of bacterial suspension can be used; the 
type of bacteria and its viability within the study 
conditions and the sterile technique that is used 
when studying the inward flow from the outer part 
of the implant. This lack of standardization in the 
methodology leads to a large amount of variability 
in the results observed in these studies29.
The lack of standardized knowledge about 
this microgap and its influence in the bacterial 
colonization and proliferation makes it difficult to 
provide information about the flow of fluids between 
the inner and outer parts of the I/A interface8. 
The hypothesis was that not only the volume of 
bacteria inoculated inside the internal cavity of 
the implant but also the tightening torque of the 
abutment screw influence bacterial microleakage 
in non-loading conditions. Therefore, the aim of 
this study was to evaluate the role of different 
abutment tightening torques in microleakage at the 
I/A interface in eH implants ad modum Brånemark 
in static conditions.
MATERIAL AND METhODS
Twenty-seven eH and external torque screw-
type cylindrical implants (3.75x11 mm) and conical 
abutments (4.1 mm platform and 4.0 mm trans-
mucosal height - NeODeNT®, Curitiba, SP, Brazil) 
were used in this study. During the first phase, 
the ideal volume of the bacterial suspension to 
be inoculated inside the implant was evaluated. 
This volume was then used in the second phase 
to evaluate the effect of the tightening torque 
(Figure 1).
Escherichia coli bacteria (ATCC 35218) was 
cultivated in brain heart infusion broth – BHI 
(Biolife, Milan, Italy) in an incubator (BIOMATIC, 
Porto Alegre, RS, Brazil) for 24 hrs at 37°C and 
used in this experiment. All of the instruments that 
were used were autoclaved at 121oC at 15 psi for 
15 minutes.
For the first phase, nine I/A sets were randomly 
inoculated with different volumes of bacterial 
suspension and divided into three groups (n=3): 
V0.5 – 0.5 µL; V1.0 – 1.0 µL and V1.5 – 1.5 µL 
(Figure 1). All of the procedures and necessary 
materials were conducted under clean conditions 
of a laminar flow hood (VECO, Campinas, Brazil). 
A standard bacterial suspension dilution of 0.5 
McFarland (108 colony forming unit/mL – CFU/
mL) was prepared and taken to the hood. Micro-
centrifuge tubes (Eppendorf, Enfield, USA) were 
filled with 140 µL of BHI by using an automatic 
pipette (20-200 µL, LABMATe+, HT-High Tech 
Laboratories, PZ HTL S.A, Warsaw, Poland). The 
implants were set on a holder and swabbed to 
evaluate the sterile condition. The swabs were 
also kept in BHI. An automatic pipette (0.1-20 µL, 
LABMATE+, HT-High Tech Laboratories, PZ HTL 
S.A, Warsaw, Poland) was fixed to the vertical 
shaft of a dental surveyor (BIOART, São Carlos, SP, 
Brazil) (Figure 2). The stabilized pipette allowed 
inoculating the amount that was necessary for 
each experimental group inside the implant internal 
cavity (screw channel).
After the implant, the internal cavity was 
inoculated, the abutment was opened and carefully 
installed by using sterile pliers. It was then tightened 
to 20 Ncm torque, according to the manufacturer’s 
recommendations, with a manual torquemeter that 
was individually calibrated for each sample. For the 
torque to be applied, the implant was kept in the 
implant holder (Figure 2e). The implant holder was 
manually stabilized during the torque. A new swab 
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was obtained from the I/A interface to assure that 
no leakage or overflow of the bacterial suspension 
had occurred during the abutment installation and 
screw tightening process. After inoculation, all of 
the implant/abutment samples and swabs were 
kept in sterile BHI broth. The tubes with implants 
and swabs were maintained in an incubator at 37°C 
for up to 14 days in order to evaluate the bacterial 
infiltration at the I/A interface.
The swabs for contamination control were 
evaluated after 24h by changes in the broth’s 
turbidity. A turbid broth indicated bacterial leakage 
during the inoculation and/or abutment installation 
and that sample would be excluded. The implant/
abutment samples were also evaluated every 24 
h by the same method to evaluate the bacterial 
microleakage at the I/A interface.
For the second phase, the materials and I/A sets 
that were used in the first phase were autoclaved 
as previously mentioned. Twenty-seven implant/
abutment sets were randomly divided into three 
groups (n=9). each group received a different 
tightening torque: T10: 10 Ncm; T20: 20 Ncm 
and T32: 32 Ncm. The amount of solution to be 
inoculated according to the first phase of this study 
was set to 0.5 µL E. coli solution at a 0.5 McFarland 
density. The protocol for inoculation, contamination 
control and incubation was maintained the same as 
the first phase. After 14 days, if no bacterial growth 
was observed, the I/A samples were opened in the 
laminar flow hood. After both phases of this study, 
the disassembled components were placed in a new 
tube with sterile BHI to verify the viability of the 
Figure 1- Study flow chart
Figure 2- Inoculation device adapted from a dental 
surveyor. A: vertical rod with pipette holder; B: screw 
to lock vertical rod; C: cross arm; D: pipette holder; E: 
implant holder
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bacteria (Figure 3). If the bacteria were not viable 
after this period, the sample would be excluded to 
prevent a false negative result.
For the statistical analysis, comparison of 
microleakage among the groups was performed 
by the Kruskal-Wallis test. The significance level 
was set at p<0.05.
RESULTS
First phase
After 24 h, all of the swabs obtained from the 
I/A interfaces after abutment installation for groups 
V1.0 and V1.5 presented bacterial growth, which 
was assessed by the turbidity of the BHI broth in 
these swabs. It demonstrated the overflow of the 
bacterial suspension. Therefore, for the second 
phase, 0.5 µL of bacterial solution was selected 
for the type of implant that was used in this study.
Second phase
After 24 h, one of the T20 group samples 
presented contamination by evaluation of the 
swab after the abutment installation; thus, it was 
excluded. During the first 24 h, two samples from 
group T10 (20%) and one sample from group T20 
(10%) presented bacterial growth and turbidity of 
the BHI broth, indicating bacterial microleakage. 
No samples from the T32 group presented bacterial 
microleakage. During 14 days, none of the other 
samples presented signs of bacterial microleakage. 
No statistically significant differences among the 
groups were observed (p<0.05). After the 14-
day period, the I/A samples were opened and the 
bacterial viability was confirmed in all the samples 
(Figure 3).
DISCUSSION
Microleakage at the I/A interface in different 
implant systems has been evaluated by using 
methods with bacteria3,4,7,10,12,16,20,21,23,24,28,30, their 
toxins29, and even dyes8,13,23. However, the results 
demonstrate great variability, suggesting that 
some limitations in these designs exist, hindering 
its reproducibility.
Microbiological studies, in general, are very 
sensitive due to the handling of biological agents. 
These biological agents are susceptible to changes 
in the working and storage environment. It is 
even more critical when that environment has 
limitations in terms of the size and source of 
nutrition and oxygen for the microorganism, as 
is the case within the implant internal cavity. It 
is important to adopt procedures to minimize 
the possibility of operator-related mistakes. It is 
also vital to establish a methodology that allows 
reproducible results among different researchers, 
which makes it possible to compare microleakage 
at the I/A interfaces of different implant systems29. 
In this study, special care was taken to keep the 
samples sterile and prevent contamination during 
inoculation by taking swabs of the external surfaces 
of each sample throughout the experiment. These 
procedures could guarantee that the only factor 
accounting for turbidity of the broth would be 
related to bacteria migrating from the implant 
internal cavity.
Some of the studies that evaluate the 
microleakage at the I/A interface use forceps to 
hold the implants when inoculating the bacteria 
and seating the abutments3,4,9,12,14,16,19,21. This 
procedure is frequently carried out with free-hand 
inoculation of the bacteria3,4,8,9,12-14,16,19,21,29,30. The 
implant internal cavity has a 2-3 mm opening, 
which is a very tight space that requires a high 
level of operator precision when inoculating the 
bacteria. Coming into contact with the implant 
internal cavity opening could lead to false positive 
results by facilitating the bacteria’s migration to the 
outside. The use of excessive force with the forceps 
close to the implant platform could also distort the 
titanium implant2, which increases the gap at the 
I/A interface and favors bacterial migration. Based 
on these facts, two devices have been developed 
for this study. The first is intended to firmly hold the 
implant at its apical portion and prevent distortion 
of the coronal aspect. The second is a pipette 
Figure 3- Bacterial viability after 14 days assessed by the turbidity of the brain heart infusion (BHI) broth. A: negative 
control; B: bacterial growth to confirm viability
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carrier that holds the pipette in a stable position 
in order to prevent the samples from becoming 
contaminated (Figure 2).
Because there are several different implant 
systems, different amounts of bacterial suspension 
have been used to inoculate the implants in 
microleakage studies3,4,9,12,14,16,19-22,29,30. The amount 
of material that is added to the implant internal 
cavity can influence bacterial leakage as it could 
express during the abutment placement. Therefore, 
the internal volume must be determined when 
designing these experiments. To minimize the risk 
of using excess material, the first step of the study 
was to evaluate the amount of bacterial suspension 
that would fit our specific implant design. The 
analysis of the turbidity of the broth with the cotton 
swabs from the outer part of the I/A interface after 
the abutment installation demonstrated bacterial 
leakage for groups V1.0 and V1.5 after 24 h. Thus, 
a 0.5-µL-bacterial suspension was used for the 
second part of this study.
The implants were covered up to the I/A 
interface4,9,12,14,16,19,30 to eliminate the flow of 
microorganisms at the abutment/screw interface, 
as has been observed in a previous study24, and also 
to eliminate the use of sealing materials3,4,19,21,23,30. 
This study used abutments with a 4 mm-high 
gingival collar to separate the abutment/screw 
interface from the BHI broth.
The bacterium that was used in this study 
was E. coli. It is a gram-negative, rod-shaped, 
facultative anaerobic bacterium that ranges from 
1.1 to 1.5 µm in diameter and 2 to 6 µm in length. 
It exhibits a high degree of motility16,30 and survival 
in adverse environments. This bacterium was 
selected because of its ability to survive the study 
conditions since the implant internal cavity would 
have a limited supply of oxygen and nutrients for 
14 days. In vitro studies that use round bacteria 
reported that most of the microleakage occurred 
in the first couple of days3,12,16,21. The same trend 
was also observed in this study, which could be due 
to the reduction of the amount of nutrients in the 
medium. It also suggests that a longer incubation 
time could lead to the death of the bacteria. After 
a 14-day follow-up, the bacteria inside the implant 
internal cavity were proven to be viable and able 
to expand after 24 h. Some studies that did not 
check the bacterial viability could obtain misleading 
conclusions regarding the microleakage at the I/A 
interface9. Microleakage that occurs only during the 
first couple of days reinforces the hypothesis that 
the conditions inside the implant’s internal cavity 
become extremely adverse to bacterial survival, 
growth, and movement through the I/A interface. 
A control group for this type of study would be a 
group that would always lead to microleakage even 
at the 0.5 µL volume by keeping a gap at the I/A 
interface. However, in this study no control group 
was selected because the idea was to evaluate the 
microleakage with different amounts of bacterial 
solution and different tightening torques.
even though two of the I/A assemblies that 
were tightened to 10 Ncm and one tightened to 20 
Ncm torque showed bacterial leakage at the I/A 
interface, a statistical evaluation did not show any 
difference among the different tightening torque 
groups. Bacterial leakage was not observed in the 
32 Ncm tightening torque group. Within these study 
conditions, torque tightening did not statistically 
affect the microleakage at the I/A interface and 
contrasts with a different study that used dyes13. 
In this study, the eH connection showed a low 
incidence of bacterial leakage at the I/A interface, 
which was also a finding that differed from previous 
studies3,10,19,21.
Based on the recent in vitro bacterial 
microleakage studies3,9,19-21 one limiting factor in 
this study was the fact that we did not use cyclic 
loading. even though there have been indications 
that with cyclic loading the microgap can increase 
and facilitate the flow of fluids, primarily in EH 
designs27,28,30. Harder and cowokers14 in 2010 
reported that more stable connections, such as a 
internal conical with a microgap of approximately 
2-4 µm, could allow the flow of toxins of minute 
sizes. These toxins come from the bacterial cell wall 
and are mainly responsible for the bone loss in the 
area18 It suggests that the bone loss is more related 
to the distance from the interface to the bone17 than 
to the bacterial flow in the area6,15,16. This study 
aimed in calculating the ideal amount of fluids 
that could be inoculated inside the implant internal 
cavity without leading to false positive or false 
negative results. This study also tried to validate 
a device that could allow adequate inoculation of 
the material without contaminating the external 
surface of the implant and abutment. Despite 
that, the results of this study indicate that in static 
conditions, implants with a 32 Ncm tightening 
torque do not allow bacterial microleakage at the 
I/A interface.
In vitro studies with microorganisms have 
some difficulties that are related to handling, 
due to the size of the implants and the challenge 
in maintaining sterile conditions throughout the 
experiment. It is also difficult to measure the 
amount of leakage that is detected at the interface 
and to conduct long-term experiments with viable 
amounts of bacteria. Nevertheless, additional 
studies should be conducted to evaluate the 
bacterial microleakage as well as that of its toxins. 
These experiments should be conducted in different 
implant systems and in different loading conditions 
to better evaluate the importance of the microgap 
on bacterial microleakage.
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The present study reinforces the importance of 
using different amounts of bacterial suspension for 
different implant systems, procedures for handling 
the implants and inoculating the bacteria, and also 
to check for the overflow of bacterial suspension 
and viability. Since this study did not use dyes 
that contain particles of approximately the same 
size as bacterial toxins and are related to bone 
loss, or cyclic loading, which can interfere with 
microleakage, it is imperative to conduct additional 
studies to address these issues.
CONCLUSION
Within the limitations of this study, it was 
concluded that the tightening torque did not 
statistically influence bacterial microleakage at 
the I/A interface of eH implants. Nonetheless, only 
the samples that were tightened to 32 Ncm failed 
to present any sign of bacterial contamination in 
static conditions. After 14 days, the bacteria in 
the internal cavity of the implant were proven 
to be viable. Regarding the amount of bacterial 
suspension that should be added to the implant 
internal cavity, this study found that 0.5 µL is the 
ideal amount to prevent overflow and cause false 
positive results. Although the in vitro methodology 
to evaluate bacterial microleakage in implants is 
efficient, it has some limitations, and operator-
dependent variables should be minimized.
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